Updates | SALASAR ENTERPRISES in Delhi,Established in 2019, Salasar Enterprises is a recognized name in the wholesale distribution of high-quality pharmaceutical medicines. We offer a comprehensive range of products, including Hepatitis Medicines, Pharmaceutical Capsules, and Tablets, sourced from reputed vendors with well-equipped manufacturing facilities. Our products are known for their high efficacy, accurate composition, and long shelf life, meeting the strictest industry quality standards. We conduct thorough quality checks at our in-house facility to ensure every batch is safe, reliable, and compliant. Backed by a team of experienced professionals, we bring deep knowledge and dedication to every aspect of our operations. Their expertise has been instrumental in building our strong reputation in this competitive market. Moreover, we are committed to offering our products at competitive and affordable prices, making quality healthcare accessible to all. Under the leadership of our mentor, Mr. Kapil Malu, we have consistently grown and expanded our client base. His strategic guidance and in-depth industry insight continue to drive our success.

Chat with us

update image

SORATIb 200mg Tablet in Washington, USA London, UK Mogadishu, Somalia Mali, Bamako-SALASAR ENTERPRIS

2025-09-11T05:19:13

update image

200 Mg Cipla Soranib Sorafenib Tablets in Washington, USA London, UK Mogadishu, Somalia Mali, Bamako

2025-09-11T05:08:50

update image

Buy Zopinap in Delhi

2025-08-14T05:27:05

update image

Buy Lamivir HBV in Delhi

2025-08-14T05:26:20

update image

Buy Zopitran in Delhi

2025-08-14T05:25:47

update image

Buy Temoside in Delhi

2025-08-14T05:24:22

update image

Buy Teevir in Delhi

2025-08-14T05:20:29

update image

Buy Acamprol in Delhi

2025-08-14T05:19:43

update image

Buy Naltima in Delhi

2025-08-14T05:19:04

update image

Buy Tenohep D in Delhi

2025-08-14T05:18:29

update image

Buy Sorafenat in Delhi

2025-08-14T05:17:45

update image

Buy Zopicon 7.5mg in Delhi

2025-08-14T05:17:13

Page 1 out of 30.17